DECITABINE vs INLEXZO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. DECITABINE and INLEXZO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DECITABINE	INLEXZO
Rating	New	New
Pharmacy pays	—	~$599.88 /30
Type	RX	RX
Active ingredient	DECITABINE	GEMCITABINE HYDROCHLORIDE
Manufacturer	Wockhardt Bio Ag	Janssen Biotech
Dosage forms	Injectable, Kit	System
Drug class	Nucleoside Metabolic Inhibitor	Nucleoside Metabolic Inhibitor
Boxed warning	None	None
Treats	Myelodysplastic Syndromes	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms

decitabine inlexzo

Rating

New

Pharmacy pays

—

~$599.88 /30

Type

Active ingredient

DECITABINE

GEMCITABINE HYDROCHLORIDE

Manufacturer

Wockhardt Bio Ag

Janssen Biotech

Dosage forms

Injectable, Kit

System

Drug class

Nucleoside Metabolic Inhibitor

Boxed warning

None

Treats

Myelodysplastic Syndromes

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms

Frequently asked questions

What is the difference between Decitabine and Inlexzo?

Decitabine contains Decitabine, while Inlexzo contains Gemcitabine Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.